Ask AI

Medical Minutes

Share

Program Content

Activities

  • IMforte WCLC 2025
    Expert Insights From WCLC 2025 on IMforte: Safety Analysis of Lurbinectedin + Atezolizumab vs Atezolizumab as First-line Maintenance Therapy in ES-SCLC
    Conference Coverage
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 24, 2026

    Expires: August 23, 2026

  • ARROS1 WCLC 2025
    Expert Insights From WCLC 2025 on ARROS-1: Phase I/II Study of Zidesamtinib for Patients With Advanced ROS1+ NSCLC After Prior ROS1 TKI
    Conference Coverage
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 26, 2026

    Expires: August 25, 2026

  • DeLLphi-303 WCLC 2025
    Expert Insights From WCLC 2025 on DeLLphi-303: 1L Maintenance Therapy With Tarlatamab + PD-L1 Inhibitor in Extensive-Stage SCLC
    Conference Coverage
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 26, 2026

    Expires: August 25, 2026

  • FLAURA2 WCLC 2025
    Expert Insights From WCLC 2025 on FLAURA2: Final Overall Survival of First-line Osimertinib ± Platinum-Based Chemotherapy in EGFR-Mutated Advanced NSCLC
    Conference Coverage
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 26, 2026

    Expires: August 25, 2026

  • Beamion LUNG 1 WCLC 2025
    Expert Insights From WCLC 2025 on Beamion LUNG-1: Phase Ib Study of Zongertinib in Patients With Previously Treated HER2-Mutant NSCLC and Baseline Brain Metastases
    Conference Coverage
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 27, 2026

    Expires: August 26, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Jazz Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.

Jazz Pharmaceuticals, Inc.